Eli Lilly (LLY)

• Market cap: $964B
• 1 day: 0.5%
• 5 days: 3.38%
• 1 month: 0.64%
• 3 months: 45.17%
• 6 months: 38.42%
• Year to date: 38.42%
• 1 year: 35.36%
• 5 years: 546.21%
• 10 years: 1,154.49%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 47,000